Cellectar Biosciences (NASDAQ: CLRB) is engaged in the development of targeted phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. It offers CLR 131, a PDC radiotherapeutic product candidate currently being evaluated in a phase I study for the treatment of relapse or refractory multiple myeloma; CLR 125, a cancer-targeting radiotherapeutic is under … Continue reading “Cellectar Biosciences (NASDAQ: CLRB) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference”
Sino-Global (NASDAQ: SINO) shares fell 21% after the company this morning announced that it has entered into definitive agreements with three institutional investors to purchase a total of $4.77 million of its common stock in a registered direct offering at $3.18 per share. The company, a non-asset based global shipping and freight logistic integrated solution provider, estimates that the net proceeds … Continue reading “NetworkNewsBreaks – Sino-Global (NASDAQ: SINO) Shares Drop on News of $4.77M Registered Direct Offering”
Shares of Qualstar (NASDAQ: QBAK) rose 14% this morning on news that the company’s N2Power Division has received a $1.0 million order from a significant gaming customer that’s expected to ship over the next 12 months. The N2Power Division is engaged in the design and manufacture of compact and highly-efficient power supplies and provides standard, … Continue reading “NetworkNewsBreaks – Qualstar Corp.’s (NASDAQ: QBAK) N2Power Division Receives $1.0M Order; Shares Rise”
IntelliPharmaCeutics International (NASDAQ: IPCI) is a pharmaceutical company that engages in the research, development, and manufacture of novel and generic controlled and targeted release oral solid dosage drugs. The company develops various drug delivery systems and a pipeline of products based on its patented Hypermatrix technology in various stages of development in therapeutic areas, such … Continue reading “IntelliPharmaCeutics International (NASDAQ: IPCI) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference”
CytoSorbents (NASDAQ: CTSO) is a critical care focused immunotherapy company engaged in the research, development and commercialization of medical devices with its platform blood purification technology that incorporates a proprietary adsorbent polymer technology. Its principal product is the CytoSorb device, an extracorporeal cytokine filter designed for the adjunctive therapy in the treatment of sepsis. CytoSorbent … Continue reading “CytoSorbents Corp. (NASDAQ: CTSO) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference”
Agenus (NASDAQ: AGEN) and Incyte (NASDAQ: INCY) are both trading higher this morning after the companies announced the amendment of an agreement signed in January, changing the ongoing GITR and OX40 antibody programs from co-funded development and profit-sharing arrangements to royalty-bearing programs. While Incyte is now responsible for funding as well as global development and … Continue reading “NetworkNewsBreaks – Amended Collaboration Pushes Agenus, Inc. (NASDAQ: AGEN), Incyte Corp. (NASDAQ: INCY) Shares Higher”
Multifaceted financial news and publishing company NetworkNewsWire this morning announced the availability of a new audio interview with SinglePoint, Inc. (OTC: SING) CEO Greg Lambrecht. In the interview, which can be heard at http://NNW.fm/SING-interview-Feb-2017, Lambrecht gives prospective investors some insight into the company’s SingleSeed Payments subsidiary, which aims to offer electronic banking services to businesses … Continue reading “NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Featured in Exclusive Audio Interview with NetworkNewsWire”
Singlepoint, Inc. (SING) SING provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. View Complete Profile
Full-service mobile technology and marketing provider SinglePoint, Inc. (OTC: SING) this morning was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” To view the show, visit www.MoneyTV.net. In this week’s episode, SinglePoint CEO Greg Lambrecht … Continue reading “NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Recent Share Price Increase in Interview on MoneyTV”
Singlepoint, Inc. (SING) SING provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. View Complete Profile
